Pedroza-Pacheco, I;
Shah, D;
Domogala, A;
Luevano, M;
Blundell, M;
Jackson, N;
Thrasher, A;
... Saudemont, A; + view all
(2016)
Regulatory T cells inhibit CD34+ cell differentiation into NK cells by blocking their proliferation.
Scientific Reports
, 6
, Article 22097. 10.1038/srep22097.
![[thumbnail of Published article]](https://discovery.ucl.ac.uk/style/images/fileicons/text.png) |
Text (Published article)
Pedroza_Pacheco_Regulatory T cells inhibit CD34+cell differentiation into NK cells by blocking their proliferation VoR.pdf Download (3MB) |
Preview |
Text (Supplementary figures and table)
Pedroza_Pacheco_Regulatory T cells inhibit CD34+cell differentiation into NK cells by blocking their proliferation Supplementary.pdf Download (4MB) | Preview |
Abstract
Graft versus Host Disease (GvHD) remains one of the main complications after hematopoietic stem cell transplantation (HSCT). Due to their ability to suppress effector cells, regulatory T cells (Tregs) have been proposed as a cellular therapy to prevent GvHD, however they also inhibit the functions of natural killer (NK) cells, key effectors of the Graft versus Leukemia effect. In this study, we have explored whether a Tregs therapy will also impact on NK cell differentiation. Using an in vitro model of hematopoietic stem cell (HSC) differentiation into NK cells, we found that activated Tregs led to a 90% reduction in NK cell numbers when added at the time of commitment to the NK cell lineage. This effect was contact dependent and was reversible upon Tregs depletion. The few NK cells that developed in these cultures were mature and exhibited normal functions. Furthermore, adoptive transfer of activated Tregs in rag(-/-) γc(-/-) mice abrogated HSC differentiation into NK cells thus confirming our in vitro findings. Collectively, these results demonstrate for the first time that activated Tregs can inhibit NK cell differentiation from HSC under specific conditions.
| Type: | Article |
|---|---|
| Title: | Regulatory T cells inhibit CD34+ cell differentiation into NK cells by blocking their proliferation |
| Location: | England |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1038/srep22097 |
| Publisher version: | http://dx.doi.org/10.1038/srep22097 |
| Language: | English |
| Additional information: | This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health > Infection, Immunity and Inflammation Dept |
| URI: | https://discovery.ucl.ac.uk/id/eprint/1483231 |
Archive Staff Only
 |
View Item |
